White Blood Cell SPECT/CT and Diabetic Foot Osteomyelitis

Diabetic Foot Osteomyelitis Clinical Trial

Official title:
Assessment of White Blood Cell SPECT/CT in Monitoring Antibiotic Treatment in Patients With Diabetic Foot Osteomyelitis

Status Recruiting

Clinical Trial Summary

Osteomyelitis is a risk factor for lower extremity amputation in diabetic people. Antibiotic therapy allows a remission in 60 to 80% of cases. However the optimal duration of antibiotic therapy remains controversy due to the absence of validated marker of osteomyelitis remission. We have previously shown that the negativity of white blood cell SPECT/CT (Single Photon Emission Computed Tomography/Computed Tomography) imaging at the end of treatment allowed to predict remission of osteomyelitis at 1 year in all cases. A positive imaging was associated with recurrence in 70% of cases. The aim of our study was to evaluate prospectively the interest of white blood cell SPECT/CT to set the duration of antibiotic therapy.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02927678
Study type	Observational
Source	Hospices Civils de Lyon
Contact	Julien Vouillarmet, MD
Phone	(4) 78 86 14 89
Email	julien.vouillarmet@chu-lyon.fr
Status	Recruiting
Phase	N/A
Start date	January 2014
Completion date	December 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06010433` - CERAMENT G Device Registry
Recruiting	`NCT05177107` - Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis	Phase 2
Completed	`NCT04240964` - Studying on the Difference Between Two Kinds of Osteomyelitis
Recruiting	`NCT05539963` - A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis of the Forefoot.	Phase 2
Not yet recruiting	`NCT04041739` - Fungal Infection in Patients With Diabetic Foot Osteomyelitis